Literature DB >> 7729447

Discrepancies in susceptibility test results for imipenem employing different in vitro test methods and DIN 58,940 breakpoints.

H Grimm1, C Hauss, A C Rodloff.   

Abstract

During the first half of 1993, bacteria that were isolated from clinical materials and found to have intermediate susceptibility by an agar dilution breakpoint method were collected in a large service laboratory in Germany. All of these isolates were gram-negative bacteria. They were re-tested employing full-scale agar dilution, broth microdilution, E-test and agar diffusion procedures. The results obtained indicated that 76.9% of the isolates were actually susceptible upon re-testing with a reference agar dilution technique. The reason for the discrepant results remained largely unclear. There was a high correlation between agar dilution and E-test results while the agreement with broth microdilution and agar diffusion was less satisfactory. It is suggested that the breakpoint between susceptible and intermediate categories currently recommended by DIN 58,940 (standard set by Deutsches Institut für Normung e.V.) be raised to reduce erroneous interpretations of minimum inhibitory concentrations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729447     DOI: 10.1007/bf02112612

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  External factors affecting imipenem performance in dried microdilution MIC plates.

Authors:  R Grist
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  False resistance to imipenem with a microdilution susceptibility testing system.

Authors:  E J O'Rourke; K G Lambert; K C Parsonnet; A B Macone; D A Goldmann
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

4.  N-formimidoyl-thienamycin activity against anaerobes: effect of the inoculum, pH and culture media.

Authors:  M V Borobio; M C Nogales; A Pascual; E J Perea
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

5.  Bioactivity of imipenem as a function of medium, time, and temperature.

Authors:  E J Baron; J A Hindler
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

6.  In vitro activity of thienamycin.

Authors:  P M Shah
Journal:  Methods Find Exp Clin Pharmacol       Date:  1981 Nov-Dec

7.  Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays.

Authors:  D J Nickolai; C J Lammel; B A Byford; J H Morris; E B Kaplan; W K Hadley; G F Brooks
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

8.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

9.  [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].

Authors:  H Grimm
Journal:  Arzneimittelforschung       Date:  1982

Review 10.  Antibacterial activity of imipenem: the first thienamycin antibiotic.

Authors:  H Kropp; L Gerckens; J G Sundelof; F M Kahan
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.